•
SL
SLNO
Soleno Therapeutics, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
2.34B
Volume
878.44K
52W High
$90.32
52W Low
$39.43
Open
$0.00
Prev Close
$43.73
Day Range
0.00 - 0.00
About Soleno Therapeutics, Inc. Common Stock
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Latest News
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
GlobeNewswire Inc.•Jan 16
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
GlobeNewswire Inc.•Jan 8
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
GlobeNewswire Inc.•Dec 30
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise
Benzinga•Dec 11
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?
The Motley Fool•Dec 4
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
GlobeNewswire Inc.•Dec 1
Soleno Therapeutics to Participate in Upcoming November Conferences
GlobeNewswire Inc.•Oct 28
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc.•Oct 28